No Result
View All Result
  • Login
  • Register
Business & Technology
SUBSCRIBE
  • .
  • Thought Leadership
  • Conversations
  • International Voices
  • News
  • Wealth
  • Digital Transformation
  • Lifestyle
  • Videos
  • Podcasts
  • .
  • Thought Leadership
  • Conversations
  • International Voices
  • News
  • Wealth
  • Digital Transformation
  • Lifestyle
  • Videos
  • Podcasts
No Result
View All Result
Biztech Asia
Home News

Company developing novel small molecule protein degraders for intractable diseases

by Jing Jee Tim
05/01/21
in News
1 min read
0
Company developing novel small molecule protein degraders for intractable diseases

Ligature Therapeutics Pte Ltd, an early-stage biotech company developing small molecule “protein degrader” therapeutics, has announced the close of USD6 million in seed round funding. The financing, led by Lightstone Ventures, with the participation of Enterprise Singapore’s investment arm, SEEDS Capital, will be used to build out the team and advance Ligature’s platform technology.

Lightstone Singapore L.P. cofounded Ligature in 2020 with its scientific founders Alvin Hung, Ph.D., Thomas Keller, Ph.D., and Congbao Kang, Ph.D. to take a novel approach to design small molecules capable of degrading disease-causing proteins. Drs Hung, Keller, and Kang are from the Experimental Drug Discovery Centre (“EDDC”), a national platform hosted by A*STAR for drug discovery and development. Ligature has signed an exclusive licensing agreement with EDDC to develop its protein degrader platform.

“Lightstone Singapore is committed to building companies based on innovative life science-related technologies developed in Singapore. The founding of Ligature is an example of our efforts to translate these Singapore-based scientific innovations into life-saving therapeutics,” said Kenneth D. Noonan, CEO of Lightstone Singapore. “By working with highly motivated scientists like Alvin, Thomas, and Congbao, we hope to build globally competitive drug discovery companies.”

“We are pleased to be co-investing with Lightstone Ventures, a globally recognised life science investor to support Ligature in accelerating their platform technology to develop novel therapeutics for patients,” said Ted Tan, Chairman of SEEDS Capital. “We will continue to work with top-tier investors to build and support deep tech startups such as Ligature, to grow the local biotech sector and further strengthen Singapore’s position as a regional Pharmbio hub.”

 

Previous Post

Commodities poised to benefit from dollar weakness in 2021

Next Post

AirAsia Group reduces stake in AirAsia India

Jing Jee Tim

Jing Jee Tim

Related Posts

SEA’s women in tech face lockdown barriers to career progression
News

SEA’s women in tech face lockdown barriers to career progression

HSBC first in Malaysia to offer e-payment solution for real estate sector
News

HSBC first in Malaysia to offer e-payment solution for real estate sector

Google will block search engine in Australia if media code is enforced
News

Google will block search engine in Australia if media code is enforced

US dollar extends its decline
News

US dollar extends its decline

MDEC commits to ‘Reinvent’ mission as it marks 25th anniversary
News

MDEC commits to ‘Reinvent’ mission as it marks 25th anniversary

Cell-based seafood producer BlueNalu raises USD60 million
News

Cell-based seafood producer BlueNalu raises USD60 million

Next Post
AirAsia Group reduces stake in AirAsia India

AirAsia Group reduces stake in AirAsia India

Singapore as springboard for British businesses expansion in the region

Singapore as springboard for British businesses expansion in the region

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

Recommended Stories

MOSTI launches RM10 million SIM grant to elevate social enterprise recovery

MOSTI launches RM10 million SIM grant to elevate social enterprise recovery

What’s the story with running a guesthouse in a Chinese village?

What’s the story with running a guesthouse in a Chinese village?

Fave announces partnership with Pine Labs to scale and grow more businesses digitally

Fave announces partnership with Pine Labs to scale and grow more businesses digitally

Popular Stories

  • Economic recovery: an elusive thought?

    Economic recovery: an elusive thought?

    0 shares
    Share 0 Tweet 0
  • Cannibalising your business can be profitable

    0 shares
    Share 0 Tweet 0
  • Sexual fulfillment builds confidence and well-being

    0 shares
    Share 0 Tweet 0
  • Tech Stocks – Ant gets stomped on but REITS offer stability amid volatility

    0 shares
    Share 0 Tweet 0
  • Singapore REITS and China tech stocks – Which should you buy?

    0 shares
    Share 0 Tweet 0

About Us

A Business and Technology digital publication that engages business leaders in business and technology conversations to help everyone pivot, adapt, and thrive in these turbulent times.

LEARN MORE »

Contact Us

Phone: 016-2011 050

Email: editor@biztech.asia

Address:
Level 18, Boutique Office 1 (B01-C)
Menara 2, No. 3, Jalan Bangsar,
KL Eco City, 59200, Kuala Lumpur.

Email Newsletter

Loading

© 2020 Business & Technology - made possible by Milestones Digital.

No Result
View All Result
  • Home
  • Thought Leadership
  • Conversations
  • International Voices
  • News
  • Wealth
  • Digital Transformation
  • Lifestyle
  • Videos
  • Podcasts
  • Login
  • Sign Up

© 2020 Business & Technology - made possible by Milestones Digital.

Welcome Back!

Sign In with Facebook
Sign In with Google
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Google
OR

Fill the forms bellow to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

will use the information you provide on this form to be in touch with you and to provide updates and marketing.